Published online May 7, 2018. doi: 10.3748/wjg.v24.i17.1859
Peer-review started: March 11, 2018
First decision: March 29, 2018
Revised: April 14, 2018
Accepted: April 23, 2018
Article in press: April 23, 2018
Published online: May 7, 2018
Core tip: Endoscopic balloon dilation (EBD) for Crohn’s disease-related fibrostenotic strictures has been recognized as a safe, and less invasive intervention with rare complications that occur in less than 3% of procedures. EBD can replace or defer surgery and help avoid frequent intestinal resections, which result in short bowel syndrome and impair quality of life. For non-complex strictures without adjacent fistulization or perforation that are less than 5 cm in length, EBD should be considered as first-line therapy. In this review we discuss safety, short and long-term outcomes, as well as adjuvant techniques of intralesional injection of steroids, anti-tumor necrosis factor, and metal stent insertion.